Welcome to The Royal Melbourne Hospital.
First in Care, Research and Learning.
The latest updates
People with epilepsy acquired following brain trauma are the focus of a new $28 million global push for a long-awaited research breakthrough to develop treatments that for the first time could prevent or mitigate this disabling and potentially life-threatening condition.31 January 2017
The findings of an international study led by Australian researchers will influence how doctors treat Multiple Sclerosis (MS) around the world.13 February 2017
A recall of EpiPen 300mcg Adrenaline Injection Syringe Auto-Injectors (Aust R 42978) has been issued on 20 March 2017.20 March 2017